checkAd
    Startseite > Aktien > Syros Pharmaceuticals > Nachrichten
    Syros Pharmaceuticals Aktie
    5,0300
     
    USD
    -1,37 %
    -0,0700 USD
    Letzter Kurs 20:16:56 Nasdaq
    5,0100
     
    USD
    100 STK
    Geldkurs 20:27:40
    5,0600
     
    USD
    200 STK
    Briefkurs 20:27:40
    ISIN: US87184Q2066 · WKN: A3DT8V · SYM: SYRS · USA

    Neueste Nachrichten

    Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Newly Diagnosed Unfit AML with RARA gene overexpression
    09.04.24 · Business Wire (engl.) · Syros Pharmaceuticals
    Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    02.04.24 · Business Wire (engl.) · Syros Pharmaceuticals
    Syros Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
    27.03.24 · Business Wire (engl.) · Syros Pharmaceuticals
    Syros Announces Completion of Enrollment of 190 Patients Necessary to Support Primary Endpoint Analysis in SELECT-MDS-1 Phase 3 Trial
    25.03.24 · Business Wire (engl.) · Syros Pharmaceuticals
    Syros to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 27, 2024
    20.03.24 · Business Wire (engl.) · Syros Pharmaceuticals
    Syros to Participate in TD Cowen 44th Annual Health Care Conference
    27.02.24 · Business Wire (engl.) · Syros Pharmaceuticals
    Syros Highlights Anticipated 2024 Milestones to Deliver on the Value of Tamibarotene
    08.01.24 · Business Wire (engl.) · Syros Pharmaceuticals
    Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
    19.12.23 · Business Wire (engl.) · Syros Pharmaceuticals
    Syros Announces Encouraging Initial Data from Randomized SELECT-AML-1 Phase 2 Clinical Trial Evaluating Tamibarotene in Combination with Venetoclax and Azacitidine
    06.12.23 · Business Wire (engl.) · Syros Pharmaceuticals
    Syros to Participate in Upcoming Investor Conferences
    21.11.23 · Business Wire (engl.) · Syros Pharmaceuticals
    Syros Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
    14.11.23 · Business Wire (engl.) · Syros Pharmaceuticals
    Syros to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023
    07.11.23 · Business Wire (engl.) · Syros Pharmaceuticals